371 related articles for article (PubMed ID: 24804860)
1. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.
Jiang G; Mendes EA; Kaiser P; Sankaran-Walters S; Tang Y; Weber MG; Melcher GP; Thompson GR; Tanuri A; Pianowski LF; Wong JK; Dandekar S
AIDS; 2014 Jul; 28(11):1555-66. PubMed ID: 24804860
[TBL] [Abstract][Full Text] [Related]
2. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
[TBL] [Abstract][Full Text] [Related]
3. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation.
Jiang G; Mendes EA; Kaiser P; Wong DP; Tang Y; Cai I; Fenton A; Melcher GP; Hildreth JE; Thompson GR; Wong JK; Dandekar S
PLoS Pathog; 2015 Jul; 11(7):e1005066. PubMed ID: 26225771
[TBL] [Abstract][Full Text] [Related]
5. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of latent HIV-1 by new semi-synthetic ingenol esters.
Pandeló José D; Bartholomeeusen K; da Cunha RD; Abreu CM; Glinski J; da Costa TB; Bacchi Rabay AF; Pianowski Filho LF; Dudycz LW; Ranga U; Peterlin BM; Pianowski LF; Tanuri A; Aguiar RS
Virology; 2014 Aug; 462-463():328-39. PubMed ID: 25014309
[TBL] [Abstract][Full Text] [Related]
7. Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal.
Spivak AM; Nell RA; Petersen M; Martins L; Sebahar P; Looper RE; Planelles V
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104276
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui.
Wang P; Lu P; Qu X; Shen Y; Zeng H; Zhu X; Zhu Y; Li X; Wu H; Xu J; Lu H; Ma Z; Zhu H
Sci Rep; 2017 Aug; 7(1):9451. PubMed ID: 28842560
[TBL] [Abstract][Full Text] [Related]
9. 4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.
De la Torre-Tarazona HE; Jiménez R; Bueno P; Camarero S; Román L; Fernández-García JL; Beltrán M; Nothias LF; Cachet X; Paolini J; Litaudon M; Alcami J; Bedoya LM
Biochem Pharmacol; 2020 Jul; 177():113937. PubMed ID: 32224142
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.
Larragoite ET; Nell RA; Martins LJ; Barrows LR; Planelles V; Spivak AM
Biochem Pharmacol; 2022 Jan; 195():114844. PubMed ID: 34801521
[TBL] [Abstract][Full Text] [Related]
11. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.
Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131
[TBL] [Abstract][Full Text] [Related]
12. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.
Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V
Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.
Yang H; Li X; Yang X; Lu P; Wang Y; Jiang Z; Pan H; Zhao L; Zhu Y; Khan IU; Shen Y; Lu H; Zhang T; Jiang G; Ma Z; Wu H; Zhu H
Antiviral Res; 2019 Sep; 169():104555. PubMed ID: 31295520
[TBL] [Abstract][Full Text] [Related]
14. Procyanidin trimer C1 derived from Theobroma cacao reactivates latent human immunodeficiency virus type 1 provirus.
Hori T; Barnor J; Nguyen Huu T; Morinaga O; Hamano A; Ndzinu J; Frimpong A; Minta-Asare K; Amoa-Bosompem M; Brandful J; Odoom J; Bonney J; Tuffour I; Owusu BA; Ofosuhene M; Atchoglo P; Sakyiamah M; Adegle R; Appiah-Opong R; Ampofo W; Koram K; Nyarko A; Okine L; Edoh D; Appiah A; Uto T; Yoshinaka Y; Uota S; Shoyama Y; Yamaoka S
Biochem Biophys Res Commun; 2015 Apr; 459(2):288-293. PubMed ID: 25727021
[TBL] [Abstract][Full Text] [Related]
15. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
J Virol; 2018 May; 92(10):. PubMed ID: 29343578
[TBL] [Abstract][Full Text] [Related]
16. Bryostatin-1 synergizes with histone deacetylase inhibitors to reactivate HIV-1 from latency.
Pérez M; de Vinuesa AG; Sanchez-Duffhues G; Marquez N; Bellido ML; Muñoz-Fernandez MA; Moreno S; Castor TP; Calzado MA; Muñoz E
Curr HIV Res; 2010 Sep; 8(6):418-29. PubMed ID: 20636281
[TBL] [Abstract][Full Text] [Related]
17. Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency.
Jiang G; Dandekar S
AIDS Res Hum Retroviruses; 2015 Jan; 31(1):4-12. PubMed ID: 25287643
[TBL] [Abstract][Full Text] [Related]
18. Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation.
Vemula SV; Maxwell JW; Nefedov A; Wan BL; Steve J; Newhard W; Sanchez RI; Tellers D; Barnard RJ; Blair W; Hazuda D; Webber AL; Howell BJ
Antiviral Res; 2017 Mar; 139():161-170. PubMed ID: 27889530
[TBL] [Abstract][Full Text] [Related]
19. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors.
Painter MM; Zaikos TD; Collins KL
J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396
[TBL] [Abstract][Full Text] [Related]
20. Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA.
Taylor JP; Armitage LH; Aldridge DL; Cash MN; Wallet MA
Biol Open; 2020 Dec; 9(12):. PubMed ID: 33234703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]